Status:

COMPLETED

MOTOR: Maternal Oral Therapy to Reduce Obstetric Risk

Lead Sponsor:

University of North Carolina, Chapel Hill

Collaborating Sponsors:

National Institute of Dental and Craniofacial Research (NIDCR)

Conditions:

Pregnancy Related

Periodontitis

Eligibility:

FEMALE

16+ years

Phase:

NA

Brief Summary

The purpose of this study is to determine whether maternal periodontal therapy (tooth cleaning) decreases the rate of preterm deliveries at \<37 weeks gestation and to determine the effects of materna...

Detailed Description

STUDY DESIGN: The intervention is designed as a multi-center, randomized, controlled, clinical trial to determine the effects of periodontal therapy on the rate of preterm birth. Study participants w...

Eligibility Criteria

Inclusion

  • Willing to be randomized and complete treatment protocols and provide informed consent
  • Planning on prenatal care and delivery at the enrollment center
  • Pregnant and able to complete periodontal treatment prior to 236 weeks gestation
  • At least 16 years old at enrollment
  • Minimum of 20 teeth present
  • Three (3) or more periodontal sites with \> 3mm clinical attachment loss

Exclusion

  • Multiple gestation
  • Positive history of HIV infection, AIDS, autoimmune disease, or diabetes (gestational diabetes is acceptable)
  • Any medical contraindication to periodontal probing or periodontal treatment that would require antibiotic prophylaxis, (e.g., congenital heart disease, use of Phen- fen for weight loss without a clear

Key Trial Info

Start Date :

February 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2010

Estimated Enrollment :

1800 Patients enrolled

Trial Details

Trial ID

NCT00097656

Start Date

February 1 2004

End Date

May 1 2010

Last Update

January 29 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of North Carolina

Chapel Hill, North Carolina, United States, 27599-7450

MOTOR: Maternal Oral Therapy to Reduce Obstetric Risk | DecenTrialz